Evonik prevails in US patent litigation against Materia Inc.
Evonik Industries AG, Essen (Germany) with its Business Line Catalysts has won a seven years long patent litigation in a jury trial in the Federal District Court in Wilmington DE, USA against Materia Inc., Pasadena CA. After a 9-day trial, the jury confirmed the validity of Evonik’s US patent 7,378,528 directed to olefin metathesis catalysts containing NHC (N-heterocyclic carbene) ligands. The Court had earlier decided that 50 of Materia’s catalysts infringe Evonik’s ‘528 patent. The Court also held previously that Evonik’s catMETium® RF metathesis catalyst products do not infringe Materia’s US patent 7,622,590. Materia provided a worldwide covenant not to sue Evonik or its customers on any patent in Materia’s ‘590 family. The jury awarded Evonik over 1.5 Million US$ which will be supplemented with interest for the entire period and additional royalties for the most recent financial periods for Materia’s infringement. Evonik has been represented by ReedSmith LLP, Wilmington DE / USA.
Evonik with its Business Line Catalysts is a global leader in producing specialty catalysts, custom catalysts and catalysts components for the Life Sciences & Fine Chemicals, Industrial & Petrochemical and Polyolefines market segments.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.
About Resource Efficiency
The Resource Efficiency segment is led by Evonik Resource Efficiency GmbH and supplies high performance materials for environmentally friendly as well as energy-efficient systems to the automotive, paints & coatings, adhesives, construction, and many other industries. This segment employed about 8,600 employees, and generated sales of around €4.3 billion in 2015.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.